Disease Information for Cytarabine (Cytosar-U) Administration/Toxicity

Ads
Laboratory Tests
Abnormal Lab Findings (Non Measured)
Macrocytosis/smear (Lab)
Associated Diseases & Rule outs
Associated Disease & Complications
Thrombotic thrombocytopenic purpura
Disease Mechanism & Classification
Drugs
DRUG/Anti-tumor antimetabolite (example)
DRUG/Breast milk secretion/Danger
DRUG/Prevents transplant/allograft rejection
DRUG/Pyrimidine antagonists (example)
DRUG/Teratogenic potential/effect (D plus )
Process
PROCESS/Medication/Drug (CONFIRM dose/before treatment)
Synonyms
Synonym
1 beta D Arabinofuranosyl 4 amino 2(1H)pyrimidinone, 1 beta D Arabinofuranosylcytosine, 2(1H) Pyrimidinone 4 amino 1 beta D arabinofuranosyl, 4 Amino 1 beta D arabinofuranosyl 2(1H) pyrimidinone, admin, Arabinofuranosylcytosine, Arabinoside Cytosine, arabinosylcytosine, Aracytidine, Beta Cytosine Arabinoside, Cytarabine, Cytarabine (product), Cytarabine (substance), CYTARABINE PREPARATION, Cytarabinum, cytosine arabinoside, Cytosine beta arabinoside, Brand name/ARA-C (Cytarabine), Brand name/Cytosar-U (Cytarabine), Brand name/Tarabine (Cytarabine), Synonym/Cytosine arabinoside administration
Treatment
Drug Dosage
DRUG/Intrathecal injection RX
Definition

Cancer chemotherapy drug; Antimetabolite class usually substituted purine or pyrimidine bases interfere with DNA synthesis.

(Edit)

External Links Related to Cytarabine (Cytosar-U) Administration/Toxicity
Google
Wikipedia
Merck
Images
PubMed (National Library of Medicine)
NGC (National Guideline Clearinghouse)
Medscape (eMedicine)
Harrison's Online (accessmedicine)
NEJM (The New England Journal of Medicine)
Ads